戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  mediastinal and cervical adenopathy, and no gastrointestinal lesion.
2 hepsin-activated chemical probe to highlight gastrointestinal lesions.
3 peutic target for diabetic wound healing and gastrointestinal lesions.
4 ed a new dimension to the assessment of many gastrointestinal lesions.
5 provides fluorescence-guided surveillance of gastrointestinal lesions and augments histopathological
6 cutaneous and internal venous malformations; gastrointestinal lesions are pathognomonic.
7 tors over low-molecular-weight heparin, with gastrointestinal lesions being a relative contraindicati
8 is in 3X mice that were more severe than the gastrointestinal lesions caused by the C. jejuni cdtB mu
9 osal dissection can remove large superficial gastrointestinal lesions in en bloc.
10             Determination of the presence of gastrointestinal lesions is critical in distinguishing s
11 sment revealed that significant increases in gastrointestinal lesions occurred following delayed bort
12 sensitivity of symptoms for the detection of gastrointestinal lesions was low, logistic-regression an
13                        The most common upper gastrointestinal lesions were esophagitis (23 patients),
14 and active bleeding had been excluded, upper gastrointestinal lesions were identified more frequently
15                                   Comparable gastrointestinal lesions were not observed in uninfected
16                                              Gastrointestinal lesions were significantly associated w